Sections
You are here: Home Adaptive designs - a growing demand

Adaptive designs - a growing demand

Following her presentation to France Biotech in March 2009 and at the SFdS annual conference in September 2009, Caroline Morgan has been asked to give a lecture on adaptive designs at the AMIPS (Association des Médecins des Industries des Produits de Santé) breakfast in Paris on 5th November 2009.

 

Jeudi 5 novembre 2009 de 8h30 à 10h30
Cercle privé Galliera de l’espace Eurosites George V
28 avenue George V – 75008 Paris
Programme

 

 

Caroline is currently the Director of Clinical Operations and Methodology Expert at Cardinal Systems. Caroline's main area of statistical interest is adaptive designs. Caroline has several publications in the statistical literature on this topic and is currently working on several clinical trials with adaptive designs such as phase II/III treatment selection.

 

Aligned with the Critical Path 2004, Cardinal Systems proposes innovative design and robust technology in order to go forward with new drug development for unmet medical needs.

Cardinal Systems has been participating in healthcare improvement through international clinical trials for over a decade. 

Since 2001, Cardinal Systems supports France Biotech and works in partnership with several international biotechnology companies, providing full services (study conception, regulatory submissions, monitoring, IRS, imaging, data management, biostatistics, scientific writing) for their Phase I/II and II/III developments.

 

 

Document Actions
Partners & Working Groups

Cardinal Systems works in partnership with O4CP for the Loulla & Philla FP7 project.

Loulla Philla

 

Cardinal Systems has been supporting France Biotech since 2001, and works closely with governmental institutions implicated in the valorisation of innovation, such as Oseo, Comite Richelieu (Pactepme) and Medicen.

France Biotech

Partners

 

Cardinal Systems participates actively in working groups, such as DIA, PSI and CDISC.

Working Groups